Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05934149 · ClinicalTrials.gov registry record

Lupus Landmark Study: A Prospective Registry and Biorepository

A clinical trial of Lupus Nephritis and Systemic Lupus Erythematosus (SLE), sponsored by Lupus Research Alliance.

Recruiting
Registry status
3,500
Enrollment target
20
Study locations

NCT05934149 is a study of Lupus Nephritis and Systemic Lupus Erythematosus (SLE) that is actively recruiting participants, run by Lupus Research Alliance. The registered enrollment target is 3,500 participants, above the 194-participant average among 30 other Lupus Nephritis trials with a reported enrollment target (1704% higher). The trial reports 20 study locations across 17 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05934149, a study of Lupus Nephritis and Systemic Lupus Erythematosus (SLE), is actively recruiting participants, sponsored by Lupus Research Alliance.

RECRUITING
Registry status
3,500 participants
Enrollment target
20
Study locations

Study Summary

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

Conditions Studied

Lupus Nephritis Systemic Lupus Erythematosus (SLE) Neuropsychiatric Systemic Lupus Erythematosus

Study Locations (20)

New York

  • The Feinstein Institutes for Medical Research - Manhasset
  • Columbia University Medical Center - New York
  • Northwell Health - New York
  • SUNY Upstate - Syracuse

Alabama

  • University of Alabama at Birmingham - Birmingham

Arizona

  • University of Arizona - Tucson

California

  • Wallace Rheumatic Studies Center - Beverly Hills

Florida

  • University of Miami - Miami

Georgia

  • Emory University - Atlanta

Illinois

  • University of Chicago - Chicago

Massachusetts

  • University of Massachusetts Memorial Health - Worcester

Trial Details

FieldValue
Enrollment Target 3,500 participants
Start Date 2023-06-28
Est. Completion 2035-12

Sponsor

Lupus Research Alliance

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05934149

The ClinicalTrials.gov registry entry for NCT05934149 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 194-participant average among 30 other Lupus Nephritis trials with a reported enrollment target (1704% higher). The listed sponsor is Lupus Research Alliance, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Lupus Nephritis appearing as the primary indexed condition, and to 0 interventions.

NCT05934149 reports 20 study locations spanning 17 distinct geographic areas - top geographies include New York, Alabama, Arizona.

Frequently Asked Questions

What is clinical trial NCT05934149 about?

NCT05934149 is a clinical study titled "Lupus Landmark Study: A Prospective Registry and Biorepository". The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

What is the current status of trial NCT05934149?

This trial is currently recruiting. The enrollment target is 3,500 participants. The study started on 2023-06-28. Estimated completion is 2035-12.

What conditions does trial NCT05934149 study?

This clinical trial studies the following conditions: Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Neuropsychiatric Systemic Lupus Erythematosus.

Who is sponsoring clinical trial NCT05934149?

This trial is sponsored by Lupus Research Alliance, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05934149 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lupus Nephritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lupus Nephritis

All registered trials for this condition

Systemic Lupus Erythematosus (SLE)

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.